Neuroprotective properties of 5-HT6 receptor ligands in the group of 2-arylpyrrole derivatives – a new insight into neurodegenerative diseases treatment strategy.

2019/33/N/NZ7/01875

Keywords

Descriptors

  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński, Collegium Medicum

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Marcin Józef Drop

Number of co-investigators in the project: 3

Call

PRELUDIUM 17 – announced on 2019-03-15

Amount awarded
139 700 PLN
Project start date
2020-02-17
Project end date
2023-02-16
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. 5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives.

    Authors:
    Drop M, Koczurkiewicz-Adamczyk P, Bento O, Pietruś W, Satała G, Blicharz-Futera K, Canale V, Grychowska K, Bantreil X, Pękala E, Kurczab R, Bojarski AJ, Chaumont-Dubel S, Marin P, Lamaty F, Zajdel P.
    Academic press:
    European Journal of Medicinal Chemistry (year: 2024, volume: 275, pages: 116615), Publisher: Elsevier Masson SAS
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2024.116615 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski